HYPER EXTEND: 2-Year Follow-up Following a Hybrid Strategy Using DES and DCB in Diffuse CAD

Published: 03 Jul 2023

  • Views:

    Views Icon 1191
  • Likes:

    Heart Icon 2
Average (ratings)
No ratings
Your rating

This video features Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, IT) presenting a dynamic poster focused on the 2-Year Follow-up of a Hybrid Strategy for Diffuse Coronary Artery Disease (CAD). He highlights the challenging nature of de novo diffuse coronary artery disease (CAD) in interventional cardiology, where limited treatment options exist beyond stent implantation. To address this, the study explores a hybrid approach combining last generation Drug-Eluting Stent (DES) and Restore® Drug-Coated Balloon (DCB) to limit the total stent length.

The one-year clinical events demonstrated promising results, particularly with a Device-Oriented Composite End-point. This video presents the 2-year clinical outcomes, offering further insights into the effectiveness of this hybrid strategy for diffuse CAD treatment.

This video is supported by Cardionovum.


You must be to comment. If you are not registered, you can register here.